当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析

华兰疫苗

(301207)

  

流通市值:121.57亿  总市值:121.65亿
流通股本:6.01亿   总股本:6.01亿

华兰疫苗(301207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.37亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益574165.53万元,未分配利润203657.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产683922.70万元,负债109757.17万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入26,775,352.591,202,505,820.54805,986,896.8459,961,774.27
营业总成本48,488,924.091,021,513,204.01757,546,402.98163,447,081.23
其他经营收益
营业利润40,498,849.71189,775,743.48139,351,616.4812,130,347.39
利润总额40,470,349.16187,785,927.55137,628,010.9111,201,943.94
净利润37,365,712.75182,919,690.84132,308,600.0520,797,156.8
每股收益
其他综合收益----
综合收益总额37,365,712.75182,919,690.84132,308,600.0520,797,156.8
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,459,134,057.684,383,156,727.064,780,080,177.714,469,705,467.84
非流动资产:
非流动资产合计2,380,092,936.442,461,105,319.052,399,289,543.022,442,690,269.55
资产总计6,839,226,994.126,844,262,046.117,179,369,720.736,912,395,737.39
流动负债:
流动负债合计1,075,676,433.661,117,018,654.741,464,360,450.82949,798,339.25
非流动负债:
非流动负债合计21,895,258.5622,953,802.2240,167,626.4144,063,360.74
负债合计1,097,571,692.221,139,972,456.961,504,528,077.23993,861,699.99
所有者权益(或股东权益):
归属于母公司股东权益合计5,741,655,301.95,704,289,589.155,674,841,643.55,918,534,037.4
股东权益合计5,741,655,301.95,704,289,589.155,674,841,643.55,918,534,037.4
负债和股东权益合计6,839,226,994.126,844,262,046.117,179,369,720.736,912,395,737.39
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计268,271,989.051,300,249,759.1865,490,687.86557,752,953.21
经营活动现金流出小计167,208,947.04943,117,554.3683,526,569.61451,974,780.09
经营活动产生的现金流量净额101,063,042.01357,132,204.8181,964,118.25105,778,173.12
投资活动产生的现金流量:
投资活动现金流入小计1,688,689,5358,089,656,260.76,262,680,030.875,201,373,034.06
投资活动现金流出小计1,769,049,054.967,909,111,927.155,773,605,406.134,988,858,844.99
投资活动产生的现金流量净额-80,359,519.96180,544,333.55489,074,624.74212,514,189.07
筹资活动产生的现金流量:
筹资活动现金流入小计0---
筹资活动现金流出小计0807,893,359.75440,093,339.95359,093,339.95
筹资活动产生的现金流量净额0-807,893,359.75-440,093,339.95-359,093,339.95
汇率变动对现金及现金等价物的影响-80,382.74120,022.51155,717.47170,007.42
现金及现金等价物净增加额20,623,139.31-270,096,798.89231,101,120.51-40,630,970.34
期末现金及现金等价物余额373,561,360.33352,938,221.02854,136,140.42582,404,049.57
补充资料:
现金及现金等价物的净增加额--270,096,798.89--40,630,970.34
最新报告期:2026-03-30
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,张云逸0.360.430.522026-03-30
TOP↑